The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome


Sahin Y. , Unluhizarci K. , Yılmazsoy A. , Yıkılmaz A. , Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, cilt.67, ss.904-908, 2007 (SCI İndekslerine Giren Dergi)

Özet

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.